|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molofsky AV, Pardal R and Morrison SJ:
Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell
Biol. 16:700–707. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fabrizi E, di Martino S, Pelacchi F and
Ricci-Vitiani L: Therapeutic implications of colon cancer stem
cells. World J Gastroenterol. 16:3871–3877. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Piscaglia AC: Stem cells, a two-edged
sword: risks and potentials of regenerative medicine. World J
Gastroenterol. 14:4273–4279. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di J, Duiveman-de Boer T, Figdor CG and
Torensma R: Aiming to immune elimination of ovarian cancer stem
cells. World J Stem Cells. 5:149–162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ginestier C, Hur MH, Charafe-Jauffret E,
et al: ALDH1 is a marker of normal and malignant human mammary stem
cells and a predictor of poor clinical outcome. Cell Stem Cell.
1:555–567. 2007. View Article : Google Scholar
|
|
7
|
Jiang F, Qiu Q, Khanna A, et al: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Purton LE: Roles of retinoids and retinoic
acid receptors in the regulation of hematopoietic stem cell
self-renewal and differentiation. PPAR Res. 2007:879342007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Purton LE, Bernstein ID and Collins SJ:
All-trans retinoic acid delays the differentiation of primitive
hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the
terminal maturation of committed granulocyte/monocyte progenitors.
Blood. 94:483–495. 1999.PubMed/NCBI
|
|
10
|
Jones RJ, Barber JP, Vala MS, Collector
MI, Kaufmann SH, Ludeman SM, Colvin OM and Hilton J: Assessment of
aldehyde dehydrogenase in viable cells. Blood. 85:2742–2746.
1995.PubMed/NCBI
|
|
11
|
Storms RW, Trujillo AP, Springer JB, Shah
L, Colvin OM, Ludeman SM and Smith C: Isolation of primitive human
hematopoietic progenitors on the basis of aldehyde dehydrogenase
activity. Proc Natl Acad Sci USA. 96:9118–9123. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hess DA, Meyerrose TE, Wirthlin L, Craft
TP, Herrbrich PE, Creer MH and Nolta JA: Functional
characterization of highly purified human hematopoietic
repopulating cells isolated according to aldehyde dehydrogenase
activity. Blood. 104:1648–1655. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Corpron CA, Black CT, Raney RB, Pollock
RE, Lally KP and Andrassy RJ: Malignant fibrous histiocytoma in
children. J Pediatr Surg. 31:1080–1083. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kanzaki T, Kitajima S and Suzumori K:
Biological behavior of cloned cells of human malignant fibrous
histiocytoma in vivo and in vitro. Cancer Res. 51:2133–2137.
1991.PubMed/NCBI
|
|
15
|
Schmidt H, Körber S, Hinze R, Taubert H,
Meye A, Würl P, Holzhausen HJ, Dralle H and Rath FW: Cytogenetic
characterization of ten malignant fibrous histiocytomas. Cancer
Genet Cytogenet. 100:134–142. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meloni-Ehrig AM, Chen Z, Guan XY,
Notohamiprodjo M, Shepard RR, Spanier SS, Trent JM and Sandberg AA:
Identification of a ring chromosome in a myxoid malignant fibrous
histiocytoma with chromosome microdissection and fluorescence in
situ hybridization. Cancer Genet Cytogenet. 109:81–85. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawashima H, Ogose A, Gu W, et al:
Establishment and characterization of a novel myxofibrosarcoma cell
line. Cancer Genet Cytogenet. 161:28–35. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gibbs CP, Kukekov VG, Reith JD,
Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and
Steindler DA: Stem-like cells in bone sarcomas: implications for
tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okita K, Ichisaka T and Yamanaka S:
Generation of germline-competent induced pluripotent stem cells.
Nature. 448:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wernig M, Meissner A, Foreman R, Brambrink
T, Ku M, Hochedlinger K, Bernstein BE and Jaenisch R: In vitro
reprogramming of fibroblasts into a pluripotent ES-cell-like state.
Nature. 448:318–324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lathia JD: Cancer stem cells: moving past
the controversy. CNS Oncol. 2:465–467. 2013. View Article : Google Scholar
|
|
23
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar
|
|
24
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and mullerian
inhibiting substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar
|
|
28
|
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai
P, Chu PW, Lam CT, Poon RT and Fan ST: Significance of
CD90+ cancer stem cells in human liver cancer. Cancer
Cell. 13:153–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Armstrong L, Stojkovic M, Dimmick I, Ahmad
S, Stojkovic P, Hole N and Lako M: Phenotypic characterization of
murine primitive hematopoietic progenitor cells isolated on basis
of aldehyde dehydrogenase activity. Stem Cells. 22:1142–1151. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Thant AA, Machida K, Ichigotani
Y, Naito Y, Hiraiwa Y, Senga T, Sohara Y, Matsuda S and Hamaguchi
M: Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2
secretion in a human lung carcinoma cell line QG90. Cancer Res.
62:3962–3965. 2002.PubMed/NCBI
|
|
32
|
Hess DA, Wirthlin L, Craft TP, Herrbrich
PE, Hohm SA, Lahey R, Eades WC, Creer MH and Nolta JA: Selection
based on CD133 and high aldehyde dehydrogenase activity isolates
long-term reconstituting human hematopoietic stem cells. Blood.
107:2162–2169. 2006. View Article : Google Scholar
|
|
33
|
Seigel GM, Campbell LM, Narayan M and
Gonzalez-Fernandez F: Cancer stem cell characteristics in
retinoblastoma. Mol Vis. 11:729–737. 2005.PubMed/NCBI
|
|
34
|
Ivashkiv LB: Jak-STAT signaling pathways
in cells of the immune system. Rev Immunogenet. 2:220–230.
2000.
|
|
35
|
Kim H, Lapointe J, Kaygusuz G, Ong DE, Li
C, van de Rijn M, Brooks JD and Pollack JR: The retinoic acid
synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate
cancer. Cancer Res. 65:8118–8124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brunk BP, Martin EC and Adler PN:
Drosophila genes posterior sex combs and suppressor two of zeste
encode proteins with homology to the murine bmi-1 oncogene. Nature.
353:351–353. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Iwama A, Oguro H, Negishi M, et al:
Enhanced self-renewal of hematopoietic stem cells mediated by the
polycomb gene product Bmi-1. Immunity. 21:843–851. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lessard J and Sauvageau G: Bmi-1
determines the proliferative capacity of normal and leukaemic stem
cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ning ZQ, Li J, McGuinness M and Arceci RJ:
STAT3 activation is required for Asp(816) mutant c-Kit induced
tumorigenicity. Oncogene. 20:4528–4536. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maucksch C, Jones KS and Connor B: Concise
review: the involvement of SOX2 in direct reprogramming of induced
neural stem/precursor cells. Stem Cells Transl Med. 2:579–583.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dailey L, Yuan H and Basilico C:
Interaction between a novel F9-specific factor and octamer-binding
proteins is required for cell-type-restricted activity of the
fibroblast growth factor 4 enhancer. Mol Cell Biol. 14:7758–7769.
1994.PubMed/NCBI
|
|
43
|
Ambrosetti DC, Basilico C and Dailey L:
Synergistic activation of the fibroblast growth factor 4 enhancer
by Sox2 and Oct-3 depends on protein-protein interactions
facilitated by a specific spatial arrangement of factor binding
sites. Mol Cell Biol. 17:6321–6329. 1997.PubMed/NCBI
|
|
44
|
Mitsui K, Tokuzawa Y, Itoh H, Segawa K,
Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Le Doussal V, Coindre JM, Leroux A, Hacene
K, Terrier P, Bui NB, Bonichon F, Collin F, Mandard AM and Contesso
G: Prognostic factors for patients with localized primary malignant
fibrous histiocytoma: a multicenter study of 216 patients with
multivariate analysis. Cancer. 77:1823–1830. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ágoston P, Kliton J, Mátrai Z and Polgár
C: Radiotherapy of soft tissue sarcomas of the extremities and
superficial trunk. Magy Onkol. 58:65–76. 2014.In Hungarian.
|
|
47
|
Castillo V, Valenzuela R, Huidobro C,
Contreras HR and Castellon EA: Functional characteristics of cancer
stem cells and their role in drug resistance of prostate cancer.
Int J Oncol. 45:985–994. 2014.PubMed/NCBI
|
|
48
|
Ding XW, Wu JH and Jiang CP: ABCG2: a
potential marker of stem cells and novel target in stem cell and
cancer therapy. Life Sci. 86:631–637. 2010. View Article : Google Scholar : PubMed/NCBI
|
